All In MedTech

Device Trial Radar · NCT00622531

Serial BNP Testing for Heart Failure Management

Utilizing, Studying, Evaluating BNP for Monitoring in Patients With Heart Failure (USE-BNP)

Last checked: Nov 20, 2026Latest source record: Nov 17, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

108

Actual

Start

Jan 2007

Primary completion

Jul 2009

Study completion Jul 2009

Sponsor

Lead sponsor
Siemens Healthcare Diagnostics IncPublic (SHL.DE)
Sponsor type
Industry
First posted
Feb 25, 2008

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The scope of the USE-BNP Trial is to investigate whether knowledge of BNP measurements, in conjunction with clinical assessment, in the outpatient setting can guide the management of therapy in patients with heart failure.

Conditions

  • Heart Failure

Interventions

  • BNP assay (Siemens ADVIA Centaur BNP)Device

    Diagnostic test

  • hidden BNP valueOther

    no intervention

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. composite endpoint of all cause mortality, hospitalization due to worsening heart failure and administration of IV drug therapy for worsening heart failure.Time frame: 12 months

Locations

11 sites in 2 countries. Site status is shown where the registry gives one.

  • Palo Alto VA Health Care System

    Palo Alto, California

10 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.